Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Oct 6, 2009

Premium

Arrayit last week launched a proteomics microarray platform for customers working in the areas of proteomics and in vitro molecular diagnostics.

Arrayit said the platform provides instrumentation, software, and consumables solution for peptide microarray analysis.


Expression Analysis launched a new grant program last week, under which four researchers will be given access to Expression Analysis' services. The firm said that two of the grants will focus on genome-wide association studies, and the other two will focus on follow-up studies to GWAS. Included in the grants is data analysis using Expression Analysis' digenysis analysis tool, which simultaneously analyzes allelic and copy number variation. Researchers may apply for the grants on Expression Analysis' website through Dec. 1.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.